We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Genetic Biomarkers in Feces Predict Colon Cancer

By LabMedica International staff writers
Posted on 09 Mar 2011
Biomarkers that predicted inflammation-associated colon cancer were found in mouse feces. More...
This is the same type of cancer associated with some common human inflammatory bowel diseases such as ulcerative colitis and Crohn's Disease.

Scientists found that the bacterium that leads to inflammation-associated colon cancer in mice first results in inflammation that can be detected by screening feces for messenger RNA of genes.

Craig Franklin, associate professor of veterinary pathobiology in the University of Missouri (MU) College of Veterinary Medicine (Columbia, MO, USA), believes that this discovery could lead to tests for similar genes present in humans with early inflammation-associated colon cancer. The study was published in the December 2010 edition of the journal Neoplasia.

"The assumption was that the gene expression couldn't be detected in fecal matter because RNA breaks down very rapidly. Historically, this was something that a lot of scientists, including us, hadn't considered," Prof. Franklin said. "But technology has evolved, and we now have the means of preserving RNA much better than we did 15 years ago."

The new testing method should decrease the number of animals needed for research and could lead to a test for humans that will replace colonoscopies.

Related Links:

University of Missouri College of Veterinary Medicine




New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Clinical Chemistry Analyzer
Yumizen C560
New
Clinical Chemistry & Immunoassay Analyzer
cobas® 6000 analyzer series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.